Artelo Biosciences, Inc. (ARTL) Financials
ARTL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 12.5 million | 5.8 million |
| Dec. 31, 2025 | 2.8 million | 4.1 million |
| Sept. 30, 2025 | 4.3 million | 4.9 million |
| June 30, 2025 | 4.4 million | 5.8 million |
ARTL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -1.2 million | 401000 |
| Dec. 31, 2025 | -2.9 million | 368000 |
| Sept. 30, 2025 | -3.5 million | 432000 |
| June 30, 2025 | -514000 | 117000 |
ARTL Net Income
No data available :(
ARTL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 10.3 million | 18000 | 59000 |
| Dec. 31, 2025 | 600000 | 29000 | 69000 |
| Sept. 30, 2025 | 1.7 million | - | 79000 |
| June 30, 2025 | 2.1 million | - | 87000 |
ARTL Shares Outstanding
ARTL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 1 | 773000 | 1.9 million | - |
| Dec. 31, 2025 | - | 893000 | 1.9 million | - |
| Sept. 30, 2025 | - | 1.3 million | 1.8 million | - |
| June 30, 2025 | - | 1.9 million | 1.3 million | - |
ARTL Cost of Revenue
No data available :(
ARTL
Price: $1.26
52 week price:
Earnings Per Share: -29.01 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36149
Market Capitalization: 3.2 million